-
The Pandemic’s Impact on Cancer Screening and Detection
Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
-
The Return to Work
What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.
by Jen Tota McGivney
-
Treating Cancer Patients With COVID-19: A New York City Experience
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
-
COVID-19 Exposes Health Inequities
At a symposium held during a virtual meeting of cancer researchers, panelists discussed the disproportionate impact COVID-19 has had on Black and Latino Americans, as well as members of other minority groups.
by Kevin McLaughlin
-
Trials Interrupted
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
by Kate Yandell
-
Cancer Care Moves Forward Amid COVID-19
Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
-
Registries Report on COVID-19 and Cancer
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
When COVID-19 Comes Home
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
-
International Perspectives on COVID-19 and Cancer
Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.
by Bradley Jones
-
Facing Cancer and a Pandemic at the Same Time
Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff